厉害_老虎社区_美港股上老虎 - 老虎社区

爱赚钱的瓜子

厉害

茅台“酱香型白酒大曲抗菌多肽可制备抗炎药物”专利获授权

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":199612793843968,"tweetId":"199612793843968","gmtCreate":1689764408349,"gmtModify":1689764409850,"author":{"id":3469825833798402,"idStr":"3469825833798402","authorId":3469825833798402,"authorIdStr":"3469825833798402","name":"爱赚钱的瓜子","avatar":"https://static.tigerbbs.com/a25f9dd9f0e446d3efad0c87609406f2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":6,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>厉害</p></body></html>","htmlText":"<html><head></head><body><p>厉害</p></body></html>","text":"厉害","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/199612793843968","repostId":2352020227,"repostType":2,"repost":{"id":"2352020227","kind":"news","pubTimestamp":1689751920,"share":"https://www.laohu8.com/m/news/2352020227?lang=&edition=full","pubTime":"2023-07-19 15:32","market":"sh","language":"zh","title":"茅台“酱香型白酒大曲抗菌多肽可制备抗炎药物”专利获授权","url":"https://stock-news.laohu8.com/highlight/detail?id=2352020227","media":"新京报网","summary":"新京报讯 据企查查消息，贵州茅台酒股份有限公司申请的“一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用”专利近日获授权。摘要显示，该发明公开了一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用，属于生物技术领域。抗菌多肽具有对革兰氏阴性菌和革兰氏阳性菌良好的抑制活性，作为天然安全的抗菌剂可作为饲料添加剂使用，也可以用于食品、化妆品或者消杀剂的制备，同时在制备预防或降低由大肠杆菌和金黄色葡萄球菌引起的肠道感染疾病的药物方面具有良好的应用前景。编辑 张明璇校对 翟永军","content":"<div>\n<p>新京报讯 据企查查消息，贵州茅台酒股份有限公司申请的“一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用”专利近日获授权。摘要显示，该发明公开了一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用，属于生物技术领域。抗菌多肽具有对革兰氏阴性菌和革兰氏阳性菌良好的抑制活性，作为天然安全的抗菌剂可作为饲料添加剂使用，也可以用于食品、化妆品或者消杀剂的制备，同时在制备预防或降低由大肠杆菌和金黄色...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023071915335282e0a597&s=b\">Web Link</a>\n\n</div>\n","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>茅台“酱香型白酒大曲抗菌多肽可制备抗炎药物”专利获授权</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n茅台“酱香型白酒大曲抗菌多肽可制备抗炎药物”专利获授权\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-07-19 15:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023071915335282e0a597&s=b><strong>新京报网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>新京报讯 据企查查消息，贵州茅台酒股份有限公司申请的“一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用”专利近日获授权。摘要显示，该发明公开了一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用，属于生物技术领域。抗菌多肽具有对革兰氏阴性菌和革兰氏阳性菌良好的抑制活性，作为天然安全的抗菌剂可作为饲料添加剂使用，也可以用于食品、化妆品或者消杀剂的制备，同时在制备预防或降低由大肠杆菌和金黄色...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023071915335282e0a597&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"600519":"贵州茅台","LU0211977185.USD":"EASTSPRING INVESTMENTS GREATER CHINA EQUITY \"A\" ACC","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","BK0175":"白马股","LU0405327494.USD":"ALLSPRING CHINA A FOCUS \"I\" (USD) ACC","BK0215":"饮品","LU0405327148.USD":"ALLSPRING CHINA A FOCUS \"A\" (USD) ACC","LU1781817850.SGD":"Blackrock Systematic China A-Share Opportunities A2 SGD-H","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","BK0183":"MSCI概念","LU0348814723.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"A\" (USD) INC  NC","BK0012":"证金概念","BK0196":"行业龙头","LU1580142542.USD":"Blackrock Systematic China A-Share Opportunities A2 USD","LU0878005551.USD":"UBS (LUX) KEY SELEC ASIA ALLOCATION OPPORTUNITY (USD) \"P\" (USD) ACC","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","LU0594300419.USD":"富达中国消费基金A","LU1688375341.USD":"贝莱德中国灵活股票基金","LU0516423174.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (USD) ACC","LU0326950275.SGD":"Schroder ISF China Opportunities A Acc SGD-H","LU1226287529.USD":"UBS (LUX) KEY SELECTION SICAV - CHINA ALLOCATION  OPPORTUNITY (USD) \"P\" (USD) ACC","LU0181495838.USD":"施罗德新兴亚洲A Acc","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","LU0873338254.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (USD) INC","LU0918141887.USD":"安联亚洲实际收益股票基金","LU0651946864.USD":"贝莱德新兴市场股票收益A2","LU1051768304.USD":"贝莱德新兴市场股票收益A6","LU0577902371.SGD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (SGD) ACC","LU0348816934.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AT\" (USD)","BK0028":"国家队","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU0650527681.SGD":"Fidelity China Consumer A-SGD","LU0251143458.SGD":"Fidelity Emerging Markets A-SGD","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","LU0577902298.EUR":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (EUR) ACC","LU0516422952.EUR":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (EUR) ACC","LU0140636845.USD":"施罗德大中华区股票A Acc","LU0048580855.USD":"富达大中华区A","LU0501845795.SGD":"瑞银大中华区股票基金P Acc SGD","LU0072913022.USD":"UBS (LUX) EQUITY FUND -  GREATER CHINA \"P\" (USD) ACC","LU0577902538.SGD":"Fullerton Lux Funds - Asia Growth and Income Equities A Acc SGD","BK0188":"融资融券","LU0577902454.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (USD) ACC","BK0187":"一线龙头","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","LU1720050803.USD":"安联全方位中国股票基金"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023071915335282e0a597&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2352020227","content_text":"新京报讯 据企查查消息，贵州茅台酒股份有限公司申请的“一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用”专利近日获授权。摘要显示，该发明公开了一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用，属于生物技术领域。抗菌多肽具有对革兰氏阴性菌和革兰氏阳性菌良好的抑制活性，作为天然安全的抗菌剂可作为饲料添加剂使用，也可以用于食品、化妆品或者消杀剂的制备，同时在制备预防或降低由大肠杆菌和金黄色葡萄球菌引起的肠道感染疾病的药物方面具有良好的应用前景。编辑 张明璇校对 翟永军","news_type":1},"isVote":1,"tweetType":1,"viewCount":947,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/199612793843968"}